Target Name: CCDC24
NCBI ID: G149473
Review Report on CCDC24 Target / Biomarker Content of Review Report on CCDC24 Target / Biomarker
CCDC24
Other Name(s): RP5-1198O20.2 | CCD24_HUMAN | CCDC24 variant 1 | MGC45441 | Coiled-coil domain-containing protein 24 (isoform 1) | Coiled-coil domain containing 24, transcript variant 1 | Coiled-coil domain-containing protein 24 | coiled-coil domain containing 24

CDC24: A Potential Drug Target for Cancer and Neurodegenerative Diseases

CCDC24 (RP5-1198O20.2) is a protein that is expressed in various tissues of the body, including the brain, lungs, heart, and gastrointestinal tract. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells. CCDC24 is a 24kDa protein that consists of 216 amino acid residues.

CDC24 is involved in many different cellular processes in the body, including cell adhesion, migration, and invasion. It is a critical protein that is involved in the development and maintenance of tissues and organs, including the brain and the nervous system.

One of the most promising aspects of CCDC24 is its potential as a drug target. CCDC24 has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It is also involved in the regulation of cellular processes that are important for the development and maintenance of tissues and organs, including the brain and the nervous system.

CDC24 has been shown to play a role in the development and progression of cancer. For example, studies have shown that high levels of CCDC24 are associated with poor prognosis in patients with pancreatic cancer. Additionally, CCDC24 has been shown to promote the growth and survival of cancer cells in cell culture and animal models.

In addition to its role in cancer, CCDC24 is also involved in the development and progression of neurodegenerative diseases. For example, studies have shown that CCDC24 is involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Additionally, CCDC24 has been shown to contribute to the regulation of neurotransmitter signaling, which is important for the function of the brain.

CDC24 is also involved in the regulation of cellular processes that are important for the development and maintenance of tissues and organs, including the brain and the nervous system. For example, studies have shown that CCDC24 is involved in the regulation of neuronal migration and the formation of neural networks in the brain. Additionally, CCDC24 has been shown to play a role in the regulation of ion channels, which are important for the function of cells.

In conclusion, CCDC24 is a protein that is involved in a variety of cellular processes in the body, including cell adhesion, migration, and invasion. It is also involved in the development and progression of cancer, neurodegenerative diseases, and autoimmune disorders. As a result, CCDC24 is a promising target for drug development. Further research is needed to fully understand the role of CCDC24 in these processes and to develop effective treatments.

Protein Name: Coiled-coil Domain Containing 24

The "CCDC24 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC24 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CCDC25 | CCDC26 | CCDC27 | CCDC28A | CCDC28B | CCDC3 | CCDC30 | CCDC32 | CCDC33 | CCDC34 | CCDC38 | CCDC39 | CCDC40 | CCDC42 | CCDC43 | CCDC47 | CCDC50 | CCDC51 | CCDC54 | CCDC57 | CCDC6 | CCDC60 | CCDC61 | CCDC62 | CCDC63 | CCDC65 | CCDC66 | CCDC68 | CCDC69 | CCDC7 | CCDC70 | CCDC71 | CCDC71L | CCDC73 | CCDC74A | CCDC74B | CCDC77 | CCDC78 | CCDC8 | CCDC80 | CCDC81 | CCDC82 | CCDC83 | CCDC85A | CCDC85B | CCDC85C | CCDC86 | CCDC87 | CCDC88A | CCDC88B | CCDC88C | CCDC89 | CCDC9 | CCDC90B | CCDC91 | CCDC92 | CCDC92B | CCDC93 | CCDC96 | CCDC97 | CCDC9B | CCDST | CCEPR | CCER1 | CCER2 | CCHCR1 | CCIN | CCK | CCK receptor | CCKAR | CCKBR | CCL1 | CCL11 | CCL13 | CCL14 | CCL15 | CCL15-CCL14 | CCL16 | CCL17 | CCL18 | CCL19 | CCL2 | CCL20 | CCL21 | CCL22 | CCL23 | CCL24 | CCL25 | CCL26 | CCL27 | CCL28 | CCL3 | CCL3-AS1 | CCL3L1 | CCL3L3 | CCL3P1 | CCL4 | CCL4L1 | CCL4L2 | CCL5